This content is restricted.
Brief
"On 20/11/2024, the French National Agency for the Safety of Medicines and Health Products (ANSM) published its annual haemovigilance report for 2023. The report reveals that most adverse effects in donors and recipients are mild and comparable to previous years, with no significant signals identified in 2023."
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested